Atea Pharmaceuticals Inc (AVIR)

Other Income/Expenses (Net)

$2.19M

Quarterly · Period ending: · USD

AVIR logo

AVIR Other Income/Expenses (Net)

Latest reported$2.19M
AVIR Quarterly Other Income/Expenses (Net) ($179.00K → $2.19M)
High-resolution chart · PNG

AVIR other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atea Pharmaceuticals Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
2,190,000
2,618,000
3,299,000
3,714,000
4,391,000
4,972,000
5,708,000
6,277,000
6,637,000
6,868,000
7,758,000
7,864,000
7,303,000
6,299,000
5,591,000
4,382,000
1,080,000
98,000
51,000
53,000
52,000
58,000
9,000
7,000
10,000
57,000
94,000
137,000
164,000
179,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.